Plasma and Intracellular Pharmacokinetics of Darunavir/Ritonavir Once Daily and Raltegravir Once and Twice Daily in HIV-Infected Individuals

類似資料

• Pharmacokinetics of Once-Daily Darunavir-Ritonavir and Atazanavir-Ritonavir over 72 Hours following Drug Cessation
  著者:: Boffito, Marta, 等
  出版事項: (2011)
• Pharmacokinetics of abacavir and its anabolite carbovir triphosphate without and with darunavir/ritonavir or raltegravir in HIV-infected subjects
  著者:: Jackson, Akil, 等
  出版事項: (2012)
• Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients
  著者:: Dickinson, L, 等
  出版事項: (2010)
• The use of a darunavir/ritonavir once-daily regimen in two pregnant women
  著者:: Lambert, JS, 等
  出版事項: (2010)
• Pharmacokinetic (PK) and pharmacodynamic analyses of once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial
  著者:: Sekar, V, 等
  出版事項: (2010)